Jasper van Grunsven
Executive Vice President and Chief Pain and New Product Planning OfficerVertex Pharmaceuticals
ProductView Profile →Head of Research · Biogen
Jane Grogan is Biogen’s head of research, an immunologist whose earlier work spans Genentech and the cell therapy companies ArsenalBio and Graphite Bio.
Last reviewed: Nov 2, 2026
Head of Research
Biogen
Last Reviewed: November 2, 2026
Jane Grogan is Biogen’s head of research, an immunologist whose earlier work spans Genentech and the cell therapy companies ArsenalBio and Graphite Bio.
Grogan trained in immunology at Leiden University and completed postdoctoral research as an Alexander von Humboldt Fellow at the DRFZ in Berlin and a Howard Hughes Fellow at the University of California, San Francisco.
From 2004 to 2019, she worked at Genentech in increasingly senior immunology and immuno-oncology positions. As head of adaptive tumor immunity and a principal scientist in cancer immunology discovery research, she investigated how T cells become activated or tolerant and how epigenetic mechanisms influence them. Her laboratory identified regulators of effector and regulatory T cells and advanced targets into clinical trials, including anti-lymphotoxin alpha for rheumatoid arthritis and anti-TIGIT for cancer immunotherapy.
Grogan’s Genentech work also linked early discovery, clinical development and business development. She was project leader for engineered T cell therapies before becoming chief scientific officer of ArsenalBio in 2019. There she led research, discovery and the preclinical pipeline, including work on its first product candidate.
She moved to Graphite Bio as chief scientific officer in 2021 and held that role until 2023. On October 2, 2023, she became Biogen’s executive vice president and head of research, joining its executive committee. Her appointment paired research leadership with Priya Singhal’s development organization in determining portfolio strategy.
Grogan earned a B.Sc. in biochemistry and pharmacology from the University of Melbourne and a Ph.D. in immunology from Leiden University. She completed postdoctoral fellowships in Berlin and at the University of California, San Francisco.